Electrical stimulation plus isometric exercise to improve blood flow in resistant high blood pressure
Official title: Effect of Combined Transcutaneous Electrical Stimulation and Isometric Exercise on Peripheral Hemodynamic Parameters in Patients With Resistant Hypertension
Run by Cairo University · NCT07383220 · Data updated 2026-11-12
This will try whether adding upper‑thoracic electrical stimulation (TENS) and isometric exercise to usual blood pressure medications can lower blood pressure and improve peripheral blood flow in men and women aged 50–60 with resistant hypertension.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 50 Years to 60 Years |
| Sex | All |
| Enrollment | 50 (estimated) |
| Sponsor | Cairo University Academic / other |
| Locations | 1 site (Port Said, Port Said Governorate) |
| Status | Recruiting |
| Started | January 15, 2026 |
| Main results expected | May 30, 2026 |
| Study ends | June 10, 2026 |
| Registry record updated | February 3, 2026 |
| Trial ID | NCT07383220 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 50–60 with a diagnosis of resistant hypertension (uncontrolled on ≥3 antihypertensive classes including a diuretic, or controlled on ≥4 medications), BMI 25–34.9 kg/m², and increased waist circumference are ideal candidates.
✕Probably not a fit
People with secondary causes of hypertension, recent major cardiovascular events, severe musculoskeletal or neurological disorders, or those outside the specified age/BMI ranges are unlikely to benefit from this protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Fifty participants aged 50–60 with resistant hypertension will be randomly assigned to medication plus a combined TENS and isometric exercise program or to medication plus a conventional physical therapy program. The TENS protocol targets cervicothoracic sympathetic outflow (C7–T4) with electrodes over the upper thoracic paraspinal muscles while isometric and other exercise components follow a prescribed physical therapy regimen. Primary outcomes are peripheral hemodynamic measures including systolic and diastolic blood pressure, mean arterial pressure, pulse pressure, and heart rate variability, measured before and after the intervention. The trial excludes secondary hypertension, recent major cardiovascular events, and severe musculoskeletal or neurologic disorders.
Why it matters
Potential benefit: If successful, this could provide a non‑drug approach to lower blood pressure and improve vascular function for people whose hypertension has not responded to standard medications.
How similar studies have gone: Small studies have suggested TENS can modulate autonomic tone and isometric exercise can improve vascular function, but the specific combination for resistant hypertension is relatively novel and not yet well studied.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age between 50 and 60 years. Both sexes were included Patients had been diagnosed with hypertension for at least 5 years. Patients had resistant hypertension according to (Whelton et al 2018), defined as: * Systolic blood pressure (SBP) ≥140 mmHg and/or diastolic blood pressure (DBP) ≥90 mmHg despite the use of three or more antihypertensive medications of different classes, including a diuretic, * or controlled blood pressure (\<140/90 mmHg) while on four or more antihypertensive medications. Body Mass Index (BMI) 25: 34.9 kg/m² Increased waist circumference, defined as: * Greater than 102 cm for males. * Greater than 88 cm for females. Exclusion Criteria: * Secondary hypertension due to identifiable causes (e.g., renal artery stenosis, primary aldosteronism, pheochromocytoma). * History of major cardiovascular events in the last 6 months (e.g., myocardial infarction, stroke, or heart failure exacerbation). * Severe musculoskeletal or neurological disorders that impair the ability to perform isometric exercise safely (e.g., recent joint replacement, severe osteoarthritis, stroke with residual motor deficit). * Contraindications to the use of Transcutaneous Electrical Nerve Stimulation (TENS): Implanted electronic devices: pacemakers, cardioverter defibrillators. Uncontrolled arrhythmias. Sever skin condition: open wounds, rashes, burns, eczema. Peripheral neuropathy or sensory loss. -Known cognitive impairment or psychiatric conditions that would limit the ability to follow instructions or provide informed consent.
Where it's running
-
Out Clinics of Port Said Hospitals
Port Said, Port Said Governorate, Egypt Recruiting
Study contacts
- Study coordinator: Mohamed Mohamed Morgan, Bachelor of Physical Therapy
- Email: m.morgan@cu.edu.eg
- Phone: 201026099152
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Fulvic acid supplements for metabolic syndrome
This study tests whether 50 mg or 100 mg of fulvic acid daily for 12 weeks can help people with metabolic syndrome or prediabetes.
-
Body Trimmer for abdominal obesity: does it help with weight loss?
This study tests whether Amway BODY TRIMMER helps people with abdominal obesity lose weight over 12 weeks.
-
Asprosin and miRNA Profiles in Young Women with Metabolic Syndrome
This study tests whether certain blood biomarkers, including asprosin and six microRNAs, differ between young women with metabolic syndrome and healthy peers.
-
Guiding Optimal Blood Pressure in Peritoneal Dialysis
This pilot tests whether aiming for a lower systolic blood pressure target (<120 mmHg) is feasible and practical for adults with end-stage kidney disease on peritoneal dialysis, compared to a <140 mmHg target.
-
Longer or shorter ablation duration in renal denervation to lower blood pressure
In people with resistant hypertension, this study tests whether treating the main renal arteries for 2 minutes per site (vs 1 minute) leads to greater blood pressure reduction.
-
New virtual care pathway for older adults with chronic diseases
A teleconsultation-based care pathway for adults 60+ with hypertension, diabetes, or dyslipidemia to see if it’s feasible and cost-saving in Malaysian primary care compared with usual clinic visits.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.